Sesamin inhibits bacterial formylpeptide-induced inflammatory responses in a murine air-pouch model and in THP-1 human monocytes

Journal of Nutrition

Volumn 140, Issue 2, 2010, Pages 377-381

  Cui, Youhong ^a,c   Hou, Xinwei ^a,b   Chen, Juan ^a   Xie, Lianying ^a   Yang, Lang ^c   Le, Yingying ^a,b  

^a Chinese Academy of Sciences   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CHEMOTACTIC PEPTIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SESAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASOPHIL; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MIGRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; EXPERIMENTAL MODEL; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKEMIA CELL; LEUKOCYTE ACTIVATION; MAST CELL LEUKEMIA; MONOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTE; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BACTERIA; BASOPHILS; BUCLADESINE; CALCIUM; CELL LINE; CELL LINE, TUMOR; CHEMOTAXIS, LEUKOCYTE; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; LEUKEMIA; LEUKEMIC INFILTRATION; LIGNANS; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MODELS, ANIMAL; MONOCYTES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NF-KAPPA B; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RECEPTORS, FORMYL PEPTIDE; SESAMUM; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); MURINAE; RATTUS;

EID: 74949088018     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.117804     Document Type: Article

References (33)

1. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 1994;12:593-633.
2. Le Y, Cui Y, Ying G, Iribarren P, Wang JM. The role of chemokine receptors in the promotion of viral infections. Contrib Microbiol. 2003;10:210-31.
3. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000;95:3032-43.
4. Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007;256:137-65.
5. Proudfoot AE, Power CA, Rommel C, Wells TN. Strategies for chemokine antagonists as therapeutics. Semin Immunol. 2003;15: 57-65.
6. Johnson Z, Schwarz M, Power CA, Wells TN, Proudfoot AE. Multifaceted strategies to combat disease by interference with the chemokine system. Trends Immunol. 2005;26:268-74.
7. Hirose N, Inoue T, Nishihara K, Sugano M, Akimoto K, Shimizu S, Yamada H. Inhibition of cholesterol absorption and synthesis in rats by sesamin. J Lipid Res. 1991;32:629-38.
8. Ashakumary L, Rouyer I, Takahashi Y, Ide T, Fukuda N, Aoyama T, Hashimoto T, Mizugaki M, Sugano M. Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism. 1999;48:1303-13.
9. Ide T, Ashakumary L, Takahashi Y, Kushiro M, Fukuda N, Sugano M. Sesamin, a sesame lignan, decreases fatty acid synthesis in rat liver accompanying the down-regulation of sterol regulatory element binding protein-1. Biochim Biophys Acta. 2001;1534:1-13.
10. Matsumura Y, Kita S, Morimoto S, Akimoto K, Furuya M, Oka N, Tanaka T. Antihypertensive effect of sesamin. I. Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Biol Pharm Bull. 1995;18:1016-9.
11. Kita S, Matsumura Y, Morimoto S, Akimoto K, Furuya M, Oka N, Tanaka T. Antihypertensive effect of sesamin. II. Protection against twokidney, one-clip renal hypertension and cardiovascular hypertrophy. Biol Pharm Bull. 1995;18:1283-5.
12. Matsumura Y, Kita S, Tanida Y, Taguchi Y, Morimoto S, Akimoto K, Tanaka T. Antihypertensive effect of sesamin. III. Protection against development and maintenance of hypertension in stroke-prone spontaneously hypertensive rats. Biol Pharm Bull. 1998;21:469-73.
13. Nakano D, Itoh C, Takaoka M, Kiso Y, Tanaka T, Matsumura Y. Antihypertensive effect of sesamin. IV. Inhibition of vascular superoxide production by sesamin. Biol Pharm Bull. 2002;25:1247-9.
14. Hirose N, Doi F, Ueki T, Akazawa K, Chijiiwa K, Sugano M, Akimoto K, Shimizu S, Yamada H. Suppressive effect of sesamin against 7,12-dimethylbenz[a]- anthracene induced rat mammary carcinogenesis. Anticancer Res. 1992;12:1259-65.
15. Hibasami H, Fujikawa T, Takeda H, Nishibe S, Satoh T, Fujisawa T, Nakashima K. Induction of apoptosis by Acanthopanax senticosus HARMS and its component, sesamin in human stomach cancer KATO III cells. Oncol Rep. 2000;7:1213-6.
16. Miyahara Y, Komiya T, Katsuzaki H, Imai K, Nakagawa M, Ishi Y, Hibasami H. Sesamin and episesamin induce apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med. 2000;6:43-6.
17. Ikeda T, Nishijima Y, Shibata H, Kiso Y, Ohnuki K, Fushiki T, Moritani T. Protective effect of sesamin administration on exercise-induced lipid peroxidation. Int J Sports Med. 2003;24:530-4.
18. Utsunomiya T, Shimada M, Rikimaru T, Hasegawa H, Yamashita Y, Hamatsu T, Yamasaki M, Kaku S, Yamada K, et al. Antioxidant and anti-inflammatory effects of a diet supplemented with sesamin on hepatic ischemia-reperfusion injury in rats. Hepatogastroenterology. 2003;50:1609-13.
19. Chavali SR, ZhongWW, Forse RA. Dietary alpha-linolenic acid increases TNF-alpha, and decreases IL-6, IL-10 in response to LPS: effects of sesamin on the delta-5 desaturation of omega6 and omega3 fatty acids in mice. Prostaglandins Leukot Essent Fatty Acids. 1998;58:185-91.
20. Utsunomiya T, Chavali SR, Zhong WW, Forse RA. Effects of sesamin-supplemented dietary fat emulsions on the ex vivo production of lipopolysaccharide-induced prostanoids and tumor necrosis factor alpha in rats. Am J Clin Nutr. 2000;72:804-8.
21. Chavali SR, Utsunomiya T, Forse RA. Increased survival after cecal ligation and puncture in mice consuming diets enriched with sesame seed oil. Crit Care Med. 2001;29:140-3.
22. Hou RC, Chen HL, Tzen JT, Jeng KC. Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport. 2003;14:1815-9.
23. Jeng KC, Hou RC,Wang JC, Ping LI. Sesamin inhibits lipopolysaccharide- induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol Lett. 2005;97:101-6.
24. Prossnitz ER, Ye RD. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol Ther. 1997;74:73-102.
25. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002;23:541-8.
26. Zhu J, Wang O, Ruan L, Hou X, Cui Y, Wang JM, Le Y. The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR. Int Immunopharmacol. 2009;9:1126-30.
27. Le Y, Ye RD, Gong W, Li J, Iribarren P, Wang JM. Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS J. 2005;272:769-78.
28. Zhou YL, Snead ML. Identification of CCAAT/enhancer-binding protein alpha as a transactivator of the mouse amelogenin gene. J Biol Chem. 2000;275:12273-80.
29. Partida-Sánchez S, Cockayne DA, Monard S, Jacobson EL, Oppenheimer N, Garvy B, Kusser K, Goodrich S, Howard M, et al. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat Med. 2001;7:1209-16.
30. Hii CS, Anson DS, Costabile M, Mukaro V, Dunning K, Ferrante A. Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response. J Biol Chem. 2004;279:49825-34.
31. Browning DD, Pan ZK, Prossnitz ER, Ye RD. Cell type- and developmental stage-specific activation of NF-kappaB by fMet-Leu-Phe in myeloid cells. J Biol Chem. 1997;272:7995-8001.
32. Pan ZK, Chen LY, Cochrane CG, Zuraw BL. fMet-Leu-Phe stimulates proinflammatory cytokine gene expression in human peripheral blood monocytes: the role of phosphatidylinositol 3-kinase. J Immunol. 2000;164:404-11.
33. Zingarelli B, Sheehan M, Wong HR. Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med. 2003;31:S105-11.